Blackstone Inc.

🇺🇸New York Stock Exchange
Back to all articles
Blackstone Inc. stock analysis BX overview
Neutral 0

Stocks making the biggest moves midday: Five Below, Broadcom, Blackstone, UnitedHealth & more

🧬 Alnylam Pharmaceuticals shares rose 4% after announcing a strategic AI collaboration with Inceptive Nucleics valued at up to $2 billion.

💼 Blackstone stock jumped 8% as investors reacted positively to news that the firm is limiting withdrawals from its Private Credit fund.

🤝 Fellow asset managers Ares Management and KKR each saw shares gain 6% in sympathy with Blackstone's move.

🏥 Humana shares rose more than 6% after Morgan Stanley raised its price target to $249, though the rating remains underweight.

💻 Broadcom shares tumbled nearly 15% after reporting fiscal second-quarter revenue of $22.19 billion, missing analyst expectations of $22.27 billion.

🤖 Despite the miss, Broadcom CEO Hock Tan reiterated that fiscal year 2027 AI chip revenue guidance remains "in excess of $100 billion."

📉 Semiconductor stocks broadly slid following Broadcom's results, with Micron down almost 7%, Intel down 2%, and AMD down 4%.

🛍️ Five Below shares fell 13% despite providing a better-than-expected outlook for second-quarter revenue and same-store sales growth.

🐾 Petco stock dropped roughly 8% after its current-quarter EBITDA forecast came in shy of Wall Street expectations.

🛡️ CrowdStrike's stock lost 6% on lackluster second-quarter guidance, causing shares of Palo Alto Networks to trade lower in sympathy.

👔 PVH stock plunged 20% after reiterating full-year earnings guidance despite posting a first-quarter earnings beat.

🏥 UnitedHealth shares climbed 5% following an upgrade from Bank of America to buy based on improving medical cost trends.

❤️‍🩹 Medtronic's stock advanced 4% after BTIG upgraded shares to buy, citing an attractive top-line setup and discount to peers.

Bullish Signals
  • Alnylam Pharmaceuticals shares advanced 4% after announcing a strategic artificial intelligence collaboration with Inceptive Nucleics valued at up to $2 billion.
  • Blackstone shares jumped 8% as the stock is now on track to snap a three-day string of losses following investor redemption news.
  • Fellow asset managers Ares Management and KKR each saw shares gain 6% in sympathy with Blackstone's positive move.
  • Humana shares rose more than 6% after Morgan Stanley raised its price target to $249 per share, suggesting roughly 24% upside from Wednesday's close.
  • Broadcom CEO Hock Tan reiterated the company's fiscal year 2027 revenue guidance for AI chips to be in excess of $100 billion.
  • Five Below provided a better-than-expected outlook with same-store sales expected to grow 7% to 9%, versus a 4.4% consensus.
  • UnitedHealth shares climbed 5% following an upgrade at Bank of America to buy from neutral due to improving medical cost trends.
  • Medtronic's stock advanced 4% after BTIG upgraded shares to buy from neutral, citing an attractive top-line setup and a discount to peers.
Risk Factors
  • Blackstone shares jumped 8% after investors appeared to shake off news regarding withdrawal limits on the Blackstone Private Credit fund following a pickup in redemption requests.
Full Analysis
Broadcom shares tumbled nearly 15% after reporting fiscal second-quarter revenue of $22.19 billion, which missed the $22.27 billion consensus estimate from analysts polled by LSEG. Despite the miss, CEO Hock Tan reiterated guidance for fiscal year 2027 AI chip revenue to be in excess of $100 billion, though semiconductor peers like Micron Technology, Intel, Advanced Micro Devices, and Arm Holdings also slid on the news. In other earnings-related moves, Five Below shares fell 13% despite providing a better-than-expected outlook with second-quarter revenue expected between $1.18 billion and $1.20 billion against $1.15 billion estimates, while Petco dropped roughly 8% after missing EBITDA expectations of $115 million with a forecast of $110 million to $112 million. CrowdStrike lost 6% on lackluster guidance with second-quarter revenue around $1.44 billion and adjusted earnings of $1.16 to $1.17 per share, while PVH plunged 20% after reiterating full-year earnings guidance despite a first-quarter earnings beat. In the healthcare sector, UnitedHealth shares climbed 5% following a Bank of America upgrade from neutral to buy based on improving medical cost trends and supportive near-term data points for the second quarter. Medtronic advanced 4% after BTIG upgraded its rating to buy from neutral following an earnings beat that showed an attractive top-line setup while trading at a discount to peers. Humana shares rose more than 6% after Morgan Stanley raised its price target to $249 per share, suggesting roughly 24% downside from Wednesday's close compared to the earlier anticipated decline of nearly 34%, though the bank maintained its underweight rating. Blackstone shares jumped 8% as investors appeared to shake off news regarding withdrawal limits on the Blackstone Private Credit fund after a pickup in redemption requests, with fellow asset managers Ares Management and KKR gaining 6% in sympathy. Alnylam Pharmaceuticals advanced 4% after announcing a strategic artificial intelligence collaboration with Inceptive Nucleics valued at up to $2 billion to aid RNA interference therapeutic discovery.